Refine
Has Fulltext
- yes (82)
Is part of the Bibliography
- yes (82) (remove)
Year of publication
Document Type
- Journal article (82) (remove)
Language
- English (82)
Keywords
- Neurobiologie (38)
- Medizin (10)
- Durchblutung (5)
- Gehirn (5)
- rats (5)
- active zone (4)
- traumatic brain injury (4)
- Hypothalamus (3)
- Prostaglandine (3)
- TRH (3)
- blood pressure (3)
- closed head injury (3)
- Mesenteric circulation (2)
- Mice (2)
- Neurophysiologie (2)
- Physiologie (2)
- blastocysts (2)
- brain development (2)
- cardiac output (2)
- contact-kinin system (2)
- factor XII (2)
- heart rate (2)
- inflammation (2)
- lines (2)
- mice (2)
- tumor necrosis factor (2)
- 2-photon microscopy (1)
- Anaphylactic shock (1)
- Anaphylaxis (1)
- Autoradiography (1)
- Axonal degeneration (1)
- BN 52021 (1)
- Biowissenschaften (1)
- Blutdruck (1)
- Brain stem (1)
- Bruchpilot (1)
- C1-inhibitor (1)
- CA2+ channels (1)
- CA3 (1)
- CA3 pyrimidal cells (1)
- CNS cancer (1)
- Cardiovascular (1)
- Cardiovascular system (1)
- Cerebral-ischemia (1)
- Cranial window (1)
- Crespi effect (1)
- Cryolesion (1)
- Drosophila melanogaster (1)
- ED2 (1)
- Endothelium (1)
- Endothelzelle (1)
- Experimental brain trauma (1)
- Fluorescence (1)
- HLA-G gene (1)
- Head-injury (1)
- Hemodynamic depression (1)
- Hemorrhage (1)
- IBA-1 (1)
- Icosanoid (1)
- In vivo imaging (1)
- In-vivo dia lysis (1)
- IntelliCage (1)
- Intravascular coagulation (1)
- Lipopolysaccharide (1)
- Lipoxin (1)
- Locus coeruleus (1)
- Microinjection (1)
- Model (1)
- Molecular-weight heparin (1)
- Mouse model (1)
- N-Acetyl-leukotriene E4 (1)
- Neurons (1)
- Neuropeptides (1)
- PAF-acether (1)
- PET (1)
- PFA in ethanol (1)
- Peptide-leukotrienes (1)
- Prostaglandins (1)
- R-715 (1)
- RIM-binding protein (1)
- RIM1α (1)
- Rat hippocampus (1)
- Rats (1)
- Renal circulation (1)
- SV pool (1)
- Secondary traumatic brain damage (1)
- Silver degeneration staining (1)
- Supraoptic nucleus (1)
- Sympathetic nervous system (1)
- T lymphocytes (1)
- T-2 toxin (1)
- TBI (1)
- TNF-α (1)
- TSPO (1)
- Thromboplastin (1)
- Thrombus formation (1)
- Thyreotropin-Releasinghormon (1)
- Trauma (1)
- Vasopressin (1)
- Ventilation (1)
- Von Willebrand factor (1)
- Willebrand-Faktor (1)
- Zell-Adhäsionsmolekül (1)
- [3H][3Me-His2]-TRH (1)
- acute brain slices (1)
- anxiety (1)
- astrocyte (1)
- astrocytes (1)
- autoradiography (1)
- benzodiazepine antagonist. (1)
- blood-brain barrier (1)
- bradykinin (1)
- brain (1)
- brain edema (1)
- cancer (1)
- catecholamlnes (1)
- cerebraI ischemia (1)
- cerebral blood flow (1)
- cerebral ischemia (1)
- chlorisondamine (1)
- chronic heart failure (1)
- compaction (1)
- cytokines (1)
- dSTORM (1)
- damage control orthopedics (1)
- dennorphin (1)
- depression (1)
- derivation (1)
- dermorphin (1)
- differentiation (1)
- diffuse (1)
- edema (1)
- electron tomography (1)
- femoral fracture (1)
- flumazenil (1)
- focal (1)
- focal brain lesion (1)
- hemorrhagic shock (1)
- high-pressure freezing (1)
- high-pressure freezing/freeze substitution (1)
- hippocampal (1)
- hippocampal mossy fiber bouton (1)
- homeostasis (1)
- hypovolemic hypotension (1)
- immune response (1)
- immunofluorescence (1)
- immunohistochemistry (1)
- in vitro (1)
- in-vitro (1)
- in-vivo (1)
- kallikrein–kinin system (1)
- kinin receptor (1)
- kinin receptors (1)
- lipopolysaccharides (1)
- locus coeruleus (1)
- metabolism (1)
- methylation (1)
- mhc molecules (1)
- microglia (1)
- mortality (1)
- mossy fiber synapses (1)
- mycotoxin (1)
- myocardial infarction (1)
- naloxonazine (1)
- naloxone (1)
- nanotopology (1)
- nervous system (1)
- neurobehavioural deficits (1)
- neuroinflammation (1)
- neuromuscular junction (1)
- neuronal damage (1)
- neurons (1)
- neuroprotection (1)
- object recognition memory (1)
- opiates (1)
- opioid peptides (1)
- opioid receptors (1)
- opioid-benzodiazepine interactions (1)
- paediatric cancer (1)
- plasticity (1)
- platelet activating factor (1)
- platelet-activating factor (1)
- platform (1)
- pluripotent (1)
- presynaptic (1)
- presynaptic plasticity (1)
- prostacyclins (1)
- proteins (1)
- rat (1)
- regional blood flow (1)
- regional blood ftow (1)
- release (1)
- renin (1)
- reperfusion (1)
- respiration (1)
- reveals (1)
- shock (1)
- specification (1)
- stem/progenitor cells (1)
- stress (1)
- subarachnoid hemorrhage (SAH) (1)
- super-resolution microscopy (1)
- sympathetic nerve activity. (1)
- synaptic ultrastructure (1)
- therapy (1)
- thromboinflammation (1)
- thrombosis (1)
- total peripheral resistance (1)
- vasopressin (1)
- weight drop (1)
- µ opioid receptors (1)
- µ·Opioid receptor subtypes (1)
- β-APP (1)
Institute
- Neurochirurgische Klinik und Poliklinik (77)
- Neurologische Klinik und Poliklinik (9)
- Physiologisches Institut (9)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (4)
- Center for Computational and Theoretical Biology (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Medizinische Strahlenkunde und Zellforschung (2)
- Kinderklinik und Poliklinik (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Rudolf-Virchow-Zentrum (2)
N-Acetyl-leukotriene E\(_4\) administered to conscious freely moving rats produced a dose-dependent vasoconstriction in the mesenteric vessels which led to profound reduction of blood flow to the gut. Renal and hindquarter blood flow and vascular resistance were not affected even by high doses of N-acetyl-leukotriene E\(_4\) . N-Acetyl-leukotriene E\(_4\) was 10-fold more potent than the thromboxane analog U-46619 and 1000-fold more potent than prostaglandin F\(_{2a}\) but 2-5-fold less potent than leukotriene D\(_4\)/E\(_4\) to induce mesenteric vasoconstriction. These data indicatc that N-acetylleukotriene E\(_4\) is a biologically active metabolite of peptide leukotrienes, and might play a role in cardiovascular derangements mediated by leukotrienes.
Lipoxin A (LXA\(_4\)) and lipoxin B\(_4\)(LXB\(_4\)) are newly discovered lipoxygenase-interacting products of leukocytes which might have a role in cardiovascular events associated with anaphylaxis. We have tested this possibility by systemic administration of both LXA\(_4\) and LXB\(_4\) to the conscious rat while monitaring systemic and regional hemodynamic changes. LXA\(_4\) and' LXB\(_4\) (l-100 pg/kg) produced dose-dependent constriction of the mesenteric vessels, up to + 123±23% and +50±9% for LXA\(_4\)/B\(_4\) , respectively. Dose-related changes were not observed in arterial blood pressure, heart rate, renal (LXB\(_4\)) and hindquarter blood ftow. We suggest that LXA\(_4\) and LXB\(_4\) might affect selective vascular beds, such as the mesenteric vessels, and contribute to variations in blood flow in specific pathophysiological states.
The endogenous opioid system includes three major families of peptides [22): dynorphins (derived from pre-proenkephalin B); endorphins (derived from pre-proopiomelanocortin) and enkephalins (derived from pre-proenkephalin A). Multiple species of opioid peptides are derived from these major precursors and many of them possess potent cardiovascular properties. Multiple forms of opioid receptors have been defined in the central nervous system. Although the relationship of these receptors to the multiple actions of the opioid systems is not weil understood, some predications can be made: in vitro the dynorphin-related peptidesbind preferentially to kappa-opioid receptors; the enkephalins bind preferentially to delta and JL-opioid receptors and while beta-endorphin binds to mu- and delta-, but not to kappa-opioid receptors. While littleis known on the roJe ofthe opioid system in normal cardiovascular regulation, it has become clear that cardiovascular stress situations substantially modify the activity ofthe endogenous opioid system. This review focuses on the mu-opioid system in the hypothalamus with special emphasis on its potential roJe in cardiovascular control of both normal and pathophysiologic states.
Trichothecenes are mycotoxins which produce Iethai toxicosis in humans and animals, yet no adequate therapeutic regimen has been developed. This study provides evidence that the selective platelet activating factor (PAF) antagonist, BN 52021 (5-15 mg/kg i.v.) can prolong the survival of conscious rats exposed to a highly Iethai T -2 toxicosis. These data also suggest that P AF is an important mediator of this unique toxicosis.
Cardioventilator responses were studied in anaesthetized rats after injections of TRH into either the lateral (i.c.v. lat) or the fourth (i.c.v. IV) cerebral ventricles. TRH induced a morerapid hypertensive effect i.c.v. IV than i.c.v. lat. Blocking of the cerebral aqueduct abolished the hypertensive and tachypnoeic effects of TRH i.c.v. lat but not those of TRH i.c.v. IV. It is concluded that TRH increased blood pressure and ventilation rate via brain stem structures close to the fourtli ventricle.
ln the present study the effects of thyrotropin releasing hormone (TRH) and its stable analogue, CG3703, on cardiac output (thermodilution, Cardiomax) and regional blood flow (BF; directional pulsed Doppler technique) were investigated in hypovolemic hypotension in the rat. In urethan-anesthetized rats TRH (0.5 or 2 mg/ kg ia) or CG3703 (0.05 or 0.5 mg/kg ia) reversed the bleeding (27% of the blood volume)-induced decreases in mean arterial ...
The acute effect ofT-2 toxemia on local blood flow and vascular resistance in hindquarter. mesenteric. and renal vascular beds was continuously measured by the directional pulsed Doppler technique in conscious, male Sprague-Dawley rats. Intravenous injection ofT-2 toxin (I mg/kg) in the conscious rat reduced blood flow and increased vascular resistance in all blood vessels studied but had no significant effect on mean arterial pressure or heart rate. The blood flow in hindquarters gradually decreased to a minimum of -77 ± 9% (mean ±SE) 6 hr after the toxin injection. The hindquarter vascular resistance concomitantly increased to a maximum value of + 323 ± 69% above thc resistance before toxin administration. Mesenteric and renal blood flow initially increased (slightly) and then gradually decreased. The maximum drop of blood flow, -90 ± 13% and -76 ± 13% for the mesenteric and renal vascular beds, respectively, was achieved 4 hr after T-2 toxin injection and the blood flow values remained low for up to 6 hr. Simultaneously with the impairment of